Literature DB >> 3178726

Theoretical treatment of tight-binding inhibition of an enzyme. Ribonuclease inhibitor as special case.

J M Fominaya1, J M García-Segura, M Ferreras, J G Gavilanes.   

Abstract

A general treatment of very tight-binding inhibition is described. It was applied to purified endogenous RNAase inhibitor from rat testis. This treatment discriminates among the different types of inhibition and allows for calculation of the inhibition parameters. When very tight-binding inhibitions are studied at similar molar concentrations of both enzyme and inhibitor, a further approach is required. This is also described and applied to the RNAase inhibitor. A Ki value of 3.2 x 10(-12) M was found for this inhibitor protein. On the basis of this result, it was considered inappropriate to classify this type of inhibitor in terms of competitive or non-competitive, as has been done for such inhibitors so far. Functional consequences of this analysis are discussed for the RNAase-RNAase inhibitor system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178726      PMCID: PMC1149328          DOI: 10.1042/bj2530517

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

3.  The graphical determination of K m and K i .

Authors:  M Dixon
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

4.  The specific velocity plot. A graphical method for determining inhibition parameters for both linear and hyperbolic enzyme inhibitors.

Authors:  A Baici
Journal:  Eur J Biochem       Date:  1981-09

5.  Ribonuclease inhibitor from human placenta: interaction with derivatives of ribonuclease A.

Authors:  P Blackburn; B L Jailkhani
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

6.  Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors.

Authors:  J F Morrison
Journal:  Biochim Biophys Acta       Date:  1969

7.  The role of lysine-41 of ribonuclease A in the interaction with RNase inhibitor from human placenta.

Authors:  P Blackburn; J G Gavilanes
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

8.  Ribonuclease inhibitors from the livers of five mammalian species.

Authors:  L E Burton; N P Fucci
Journal:  Int J Pept Protein Res       Date:  1982-04

9.  Identification of lysine residues in the binding domain of ribonuclease A for the RNase inhibitor from human placenta.

Authors:  P Blackburn; J G Gavilanes
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

10.  Ribonuclease inhibitor from human placenta. Purification and properties.

Authors:  P Blackburn; G Wilson; S Moore
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

View more
  2 in total

1.  Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

Authors:  B S Murthy; R Sirdeshmukh
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

2.  Variants of ribonuclease inhibitor that resist oxidation.

Authors:  B M Kim; L W Schultz; R T Raines
Journal:  Protein Sci       Date:  1999-02       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.